SUBSCRIPTION AGREEMENTSubscription Agreement • June 5th, 2015 • Actinium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
ACTINIUM PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share Placement Agent AgreementPlacement Agent Agreement • June 5th, 2015 • Actinium Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Actinium Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to certain purchasers, pursuant to the terms of this Placement Agency Agreement (this “Agreement”) and the Subscription Agreements in form attached hereto as Exhibit A (the “Subscription Agreement”) entered into with the purchasers identified therein (each, a “Purchaser” and collectively, the “Purchasers”), One Million Nine Hundred Twenty-Three and Seventy-Eight (1,923,078) shares (the “Securities”) of its common stock, par value $0.001 per share (the “Common Stock”). The Company desires to engage Laidlaw & Company (UK) Ltd. as the exclusive placement agent (collectively, the “Placement Agent”) and Laidlaw & Company (UK) Ltd. as the representative of the several Placement Agents (the “Representative”) in connection with the offering, issuance and sale of the Securities.
